1-5 of 5
Linda N. Liu
Close
Sort by
Journal Articles

A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells

Linjie Tian, Ana Paucarmayta, Rustin Lovewell, Karla Maloveste, Junshik Hong, Carly Hedgepath, Kwang Woon Kim, Ron Copeland, Thomas O'Neill, Shashank Patel, Linda N. Liu, Han Myint, Solomon Langermann, Dallas B Flies, Tae Kon Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3413.
https://doi.org/10.1182/blood-2021-147656
Published: 2021
Journal Articles

Siglec-15 Is a Novel Immunomodulatory Protein and Therapeutic Target in Acute Lymphoblastic Leukemia

Claire E. Pillsbury, Jairo A. Fonseca, Jodi Dougan, Hasan Abukharma, Gloria Gonzalez-Flamenco, Sunita I. Park, Linda N. Liu, Christopher C. Porter
Journal: Blood
Blood (2021) 138 (Supplement 1): 515.
https://doi.org/10.1182/blood-2021-153647
Published: 2021
Journal Articles

Siglec-15 Is a Novel Immunomodulatory Protein and Therapeutic Target in Childhood Leukemia

Claire E. Pillsbury, Jairo A. Fonseca, MD, Jodi Dougan, Hasan Abukharma, Linda N. Liu, PhD, Christopher C. Porter, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-142833
Published: 2020
Journal Articles

An Improved, Non-Viral Approach for Production of hCD40L + B-CLL Cells for Cancer Immunotherapy.

Linhong Li, PhD, Cornell Allen, MS, Stephanie Feller, MS, Larry Wolfraim, PhD, Angelia Viley, MS, Joseph C. Fratantoni, MD, Linda N. Liu, PhD
Journal: Blood
Blood (2006) 108 (11): 2107.
https://doi.org/10.1182/blood.V108.11.2107.2107
Published: 2006
Journal Articles

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Joseph C. Fratantoni, MD, Linhong Li, PhD, Linda N. Liu, PhD, Madhusudan V. Peshwa, PhD, Malcolm Brenner, MD, PhD, Eric Yvon, MS, George Carrum, MD, Ettore Biagi, MD
Journal: Blood
Blood (2005) 106 (11): 450.
https://doi.org/10.1182/blood.V106.11.450.450
Published: 2005